Journal article

Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic

Matthias Schmitz, Elisabeth Ebert, Katharina Stoeck, Andre Karch, Steven Collins, Miguel Calero, Theodor Sklaviadis, Jean-Louis Laplanche, Ewa Golanska, Ines Baldeiras, Katsuya Satoh, Raquel Sanchez-Valle, Anna Ladogana, Anders Skinningsrud, Anna-Lena Hammarin, Eva Mitrova, Franc Llorens, Yong Sun Kim, Alison Green, Inga Zerr

Molecular Neurobiology | SPRINGER | Published : 2016

Grants

Awarded by EU Joint Program Neurodegenerative Disease Research JPND-DEMTEST (Biomarker based diagnosis of rapid progressive dementias-optimization of diagnostic protocols)


Awarded by Robert Koch Institute through funds from the Federal Ministry of Health


Awarded by European Commission (Protecting the food chain from prions: shaping European priorities through basic and applied research (PRIORITY)


Awarded by NHMRC Practitioner Fellowship



Awarded by Medical Research Council


Funding Acknowledgements

The study was performed within the recently established Clinical Dementia Center at the University Medical Center Gottingen and was supported by grants from the EU Joint Program Neurodegenerative Disease Research [JPND-DEMTEST (Biomarker based diagnosis of rapid progressive dementias-optimization of diagnostic protocols, 01ED1201A)]. This study was also partly supported by the Robert Koch Institute through funds from the Federal Ministry of Health (grant no. 1369-341) and by a grant from the European Commission (Protecting the food chain from prions: shaping European priorities through basic and applied research (PRIORITY, No. 222887) Project number: FP7-KBBE-2007-2A). Thanks to Michele Equestre for technical assistance. The Australian National CJD Registry is funded by the Commonwealth Department of Health and S Collins is supported by a NHMRC Practitioner Fellowship (#APP1005816).